EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut Microbiota, Intestinal Barrier Function, and Metabolism Across Adiposity and Glucose Tolerance

Karynne Grutter Lopes iD, Maria das Graças Coelho de Souza iD, Fernanda de Azevedo Marques Lopes, Vicente Lopes da Silva Júnior, Ana Teresa Pugas Carvalho, Davy Carlos Mendes Rapozo, Carolina Monteiro de Lemos Barbosa, Eliete Bouskela iD, Raquel Carvalho Castiglione iD, Rodolpho Matos Albano iD, Luiz Guilherme Kraemer-Aguiar iD

Nutrients · 2025

DOI: 10.3390/nu17213380 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Karynne Grutter Lopes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Clinical and Experimental Physiopathology (Fisclinex), Faculty of Medical Sciences, State University of Rio de Janeiro, Rio d…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Intestinal Mucosa, Obesity, Adiposity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro, National Council for Scientific and Technologic Development, Coordination for the Improvement of Higher Education Personnel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Obesity and dysglycemia are increasingly associated with intestinal barrier dysfunction and alterations in gut microbiota. Intestinal hyperpermeability is emerging as a therapeutic target in metabolic disorders, but human data integrating barrier biomarkers, epithelial morphology, and microbial composition remain scarce.

Methods

Forty-six adults (82.6% female; 38.3 ± 7.8 years) were stratified into lean normoglycemic controls (CON), individuals with obesity and normoglycemia (NOB), and those with obesity and dysglycemia (DOB). Biochemical/inflammatory biomarkers, such as lipopolysaccharide (LPS) and LPS-binding protein (LBP), were measured. Duodenal biopsies were obtained by upper digestive videoendoscopy. Histomorphometry, expression of junctional and cytoskeletal proteins, and enzymatic activity of the duodenal epithelium were used as markers of intestinal permeability. Fecal microbiota composition (FMC) was analyzed by amplifying the V4 region of the 16S rRNA gene, which was sequenced using next-generation sequencing technology.

Results

Duodenal histomorphometry did not differ across groups. Intestinal alkaline phosphatase (IAP) was significantly lower in DOB compared to CON. LPS correlated positively with fat mass, and LBP with the waist-to-hip ratio. The villus-to-crypt ratio correlated negatively with BMI, while IAP correlated inversely with fasting glucose and HbA1c. β-actin expression was inversely associated with BMI, glucose, insulin, and HOMA-IR. Microbiota diversity indices were similar between groups, although specific taxa, particularly within the Clostridiales order, were reduced in dysglycemia.

Conclusions

Reduced IAP activity and consistent correlations between barrier biomarkers and metabolic parameters highlight intestinal barrier dysfunction as a relevant feature of obesity and dysglycemia. Subtle microbiota alterations further support a link between gut ecology and metabolic control. These findings underscore the intestinal barrier as a promising therapeutic target in metabolic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeIntestinal MucosaObesityAdiposityGlucose IntoleranceHumansFemaleAdultMaleMiddle AgedFecesBiomarkersDuodenumPermeabilityBlood GlucoseIntestinal Barrier FunctionAcute-Phase ProteinsCarrier ProteinsMembrane GlycoproteinsLipopolysaccharide-Binding Protein

Stichwörter der Autor:innen

inflammationintestinal epithelial permeabilitymicrobiotaobesityβ-actin

Substanzen

BiomarkersBlood GlucoseAcute-Phase ProteinsCarrier ProteinsMembrane GlycoproteinsLipopolysaccharide-Binding Protein

Autor:innen und Institutionen

  • Postgraduate Program in Clinical and Experimental Physiopathology (Fisclinex), Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro 20550-013, Brazil.
  • Laboratory for Clinical and Experimental Research on Vascular Biology (Biovasc), Biomedical Center, State University of Rio de Janeiro, Rio de Janeiro 20550-013, Brazil.
  • Department of Physiological Sciences, Roberto Alcantara Gomes Biology Institute, State University of Rio de Janeiro, Rio de Janeiro 20550-013, Brazil.
  • Multiuser Clinical Research Center (CePeM), Pedro Ernesto University Hospital (HUPE), State University of Rio de Janeiro, Rio de Janeiro 20550-013, Brazil.
  • Gastroenterology, Department of Internal Medicine, Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro 20550-013, Brazil.
  • Research Center, Brazilian National Cancer Institute (INCA), Rio de Janeiro 20231-050, Brazil.

ORCID-Profile: Karynne Grutter Lopes, Maria das Graças Coelho de Souza, Eliete Bouskela, Raquel Carvalho Castiglione, Rodolpho Matos Albano, Luiz Guilherme Kraemer-Aguiar

Förderung

  • Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro
  • National Council for Scientific and Technologic Development
  • Coordination for the Improvement of Higher Education Personnel

Zitieren

APA

Lopes, K. G., de Souza, M. D. G. C., Marques Lopes, F. A., da Silva Júnior, V. L., Carvalho, A. T. P., Rapozo, D. C. M., de Lemos Barbosa, C. M., Bouskela, E., Castiglione, R. C., Albano, R. M., & Kraemer-Aguiar, L. G. (2025). Gut Microbiota, Intestinal Barrier Function, and Metabolism Across Adiposity and Glucose Tolerance. Nutrients. https://doi.org/10.3390/nu17213380

Vancouver

Lopes KG, de Souza MDGC, Marques Lopes FA, da Silva Júnior VL, Carvalho ATP, Rapozo DCM, et al. Gut Microbiota, Intestinal Barrier Function, and Metabolism Across Adiposity and Glucose Tolerance. Nutrients. 2025. doi:10.3390/nu17213380

BibTeX
@article{Lopes2025,
  author = {Lopes, Karynne Grutter and de Souza, Maria das Graças Coelho and Marques Lopes, Fernanda de Azevedo and da Silva Júnior, Vicente Lopes and Carvalho, Ana Teresa Pugas and Rapozo, Davy Carlos Mendes and de Lemos Barbosa, Carolina Monteiro and Bouskela, Eliete and Castiglione, Raquel Carvalho and Albano, Rodolpho Matos and Kraemer-Aguiar, Luiz Guilherme},
  title = {Gut Microbiota, Intestinal Barrier Function, and Metabolism Across Adiposity and Glucose Tolerance},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17213380}
}
Kostenlos starten →